Dublin, June 23, 2023 (GLOBE NEWSWIRE) -- The "Continuous Glucose Monitoring Devices Market Size, Share & Trends Analysis Report By Component (Transmitters, Sensors, Receivers), By End-use (Hospitals, Home Care), By Connectivity, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global continuous glucose monitoring devices market size is expected to reach USD 11.2 billion by 2030, registering a CAGR of 4.4% from 2023 to 2030. The two primary factors propelling the market expansion are the rise in diabetes incidences and the launch of technologically advanced diabetes care devices. Continuous glucose monitoring (CGM) devices are effective to evaluate body glucose levels in real-time. These devices transmit the data they collect across a wireless network to receivers, which aids in tracking the levels of glucose during a certain time.
While lowering individual insulin dosages, these devices also assist in managing diabetes. These devices' built-in software gives users access to information on food consumption, medicine use, physical activity, and illnesses. As a result, a growing number of diabetic patients are employing these devices to control and treat their condition, which is fueling market expansion.
A growing number of continuous glucose monitoring devices are being integrated with apps and software to assist patients with diabetes mellitus as a result of the development of digital treatments. Apps such as Glucose buddy, Diabetes Connect, My Sugar, and others are available under a paid subscription.
Furthermore, the rise in the number of diabetes mellitus has contributed significantly toward the CGM systems market growth. The device allows real-time biofeedback and behavioral change support, allowing effective management of diabetes by the patient. Additionally, the government is spending a huge amount on diabetic care tools to closely monitor diabetes in patients.
For instance, according to the International Diabetes Federation, 32.2 million Americans lived with diabetes in 2021. The same source stated that diabetes-related healthcare expenditure was about 11,779.2 USD per person in the U.S., which is expected to increase to 12,184.8 USD by 2045. Such, initiatives are said to influence market growth.
Continuous Glucose Monitoring Devices Market Report Highlights
- By component, the sensors segment held a major share of the global market in 2022, owing to the integral nature of these devices
- By end-use, the home care segment dominated the market in 2022, owing to favorable reimbursement and higher adoption especially due to the outbreak of the COVID-19 pandemic, and the rise in virtual care
- The Bluetooth segment held the larger share of 56.3% in the connectivity segment, due to the need for the replacement of Bluetooth-enabled sensors and the cost associated with its manufacturing
- North America dominated the market in 2022, attributed to the wide usage of CGM devices as a result of a higher number of target patients in the region
- Europe followed North America closely in terms of market revenue due to a rise in the adoption of these devices in key countries
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 120 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value (USD) in 2022 | $7816.8 Million |
| Forecasted Market Value (USD) by 2030 | $11200 Million |
| Compound Annual Growth Rate | 4.4% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Component
1.1.2. End-use
1.1.3. Connectivity
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Continuous Glucose Monitoring Devices Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Stage
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Increasing prevalence of diabetes globally
3.4.1.2. Technological advancements
3.4.1.3. Favorable reimbursement scenario
3.4.2. Market Restraint Analysis
3.4.2.1. High cost and low awareness
3.5. Continuous Glucose Monitoring Devices: Market Analysis Tools
Chapter 4. Continuous Glucose Monitoring Devices Market: Segment Analysis, by Product, 2018 - 2030 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Continuous Glucose Monitoring Devices Market, by product, 2018 to 2030
4.5. Market Size & Forecasts and Trend Analysis, 2018 to 2030 for the following
4.5.1. Sensors
4.5.2. Transmitters
4.5.3. Receivers
Chapter 5. Continuous Glucose Monitoring Devices Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)
5.1. Definitions & Scope
5.2. End-use market share analysis, 2022 & 2030
5.3. Segment Dashboard
5.4. Global Continuous Glucose Monitoring Devices Market, By End Use, 2018 to 2030
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.2. Home Care
5.5.3. Others
Chapter 6. Continuous Glucose Monitoring Devices Market: Segment Analysis, By Connectivity, 2018 - 2030 (USD Million)
6.1. Definitions & Scope
6.2. Connectivity market share analysis, 2022 & 2030
6.3. Segment Dashboard
6.4. Global Continuous Glucose Monitoring Devices Market, By Connectivity, 2018 to 2030
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Bluetooth
6.5.2. 4G
Chapter 7. Continuous Glucose Monitoring Devices Market: Regional Market Analysis, 2018 - 2030 (USD Million)
7.1. Definitions & Scope
7.2. Regional Market Share Analysis, 2022 & 2030
7.3. Regional Market Dashboard
7.4. Regional Market Snapshot
7.5. Regional Market Share, 2022
7.6. Market Size, & Forecasts, and Trend Analysis, 2018 to 2030:
7.7. North America
7.8. Europe
7.9. Asia Pacific
7.10. Latin America
7.11. Middle East and Africa
Chapter 8. Continuous Glucose Monitoring Devices Market - Competitive Analysis
8.1. Key companies profiled
8.1.1. Medtronic
8.1.2. Dexom, Inc.
8.1.3. F. Hoffmann-La Roche Ltd.
8.1.4. Abbott
8.1.5. Ypsomed
8.1.6. GlySens, Inc.
8.1.7. Ascensia Diabetes Care
For more information about this report visit https://www.researchandmarkets.com/r/xu3kcb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
